NCT05680740: A trial that was reported late by Organon and Co
This trial has reported, although it was 11 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05680740 |
|---|---|
| Title | A Phase 4, Open-label, Study to Investigate the Efficacy and Safety of VTAMA® (Tapinarof) Cream 1% in the Treatment of Plaque Psoriasis in Intertriginous Areas |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 27, 2022 |
| Completion date | May 18, 2023 |
| Required reporting date | May 17, 2024, midnight |
| Actual reporting date | May 29, 2024 |
| Date last checked at ClinicalTrials.gov | Dec. 3, 2025 |
| Days late | 11 |